Effectiveness of regdanvimab treatment for SARS-CoV-2 delta variant, which exhibited decreased in vitro activity: a nationwide real-world multicenter cohort study.
Kim H, Jang YR, Lee JY, Ko JH, Lee JY, Cho S, Lee YD, Song J, Hyun M, Kim HA, Hwang S, Ryou S, Na YJ, Lee JY, Lee C, Lee NY, Shin S, Kwon KT, Kim JY, Peck KR.
Kim H, et al. Among authors: lee yd.
Front Cell Infect Microbiol. 2023 May 15;13:1192512. doi: 10.3389/fcimb.2023.1192512. eCollection 2023.
Front Cell Infect Microbiol. 2023.
PMID: 37256107
Free PMC article.